All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

A novel class of bis-indole compounds capable of enhancing the cyto-differentiating effect of retinoids in acute promyelocytic leukemia cells.

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F62157124%3A16370%2F01%3A00000614" target="_blank" >RIV/62157124:16370/01:00000614 - isvavai.cz</a>

  • Result on the web

  • DOI - Digital Object Identifier

Alternative languages

  • Result language

    angličtina

  • Original language name

    A novel class of bis-indole compounds capable of enhancing the cyto-differentiating effect of retinoids in acute promyelocytic leukemia cells.

  • Original language description

    All-trans retinoic acid (ATRA) is the only example of clinically useful cyto-differentiating agent, causing complete remission in acute promyelocytic leukemia (APL) patients. However, the clinical use of ATRA is limited by a number of problems, which include a narrow spectrum of activity , systemic and local toxicity, as well as induced resistance. Using the APL-derived and ATRA-sensitive NB4 cell line, we identified a novel class of retinoid sensitizers characterized by a bis-indole chemical structure.The prototypic molecule is ST1346. When NB4 cells are challenged with ST1346 (1-10 micromolar) alone for three days, no significant growth inhibition or cyto-differentiation is observed. By contrast, the induction of several granulocytic maturation markers triggered by ATRA is enhanced by the combination of ST1346+ATRA. The bis-indole shifts the cyto-differentiating activity of ATRA to lower concentrations without affecting the anti-proliferative activity of the retinoid. These potentia

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FR - Pharmacology and apothecary chemistry

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    Z - Vyzkumny zamer (s odkazem do CEZ)

Others

  • Publication year

    2001

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Supplement to Clinical Cancer Research

  • ISSN

    1078-0432

  • e-ISSN

  • Volume of the periodical

    7

  • Issue of the periodical within the volume

    11

  • Country of publishing house

    CZ - CZECH REPUBLIC

  • Number of pages

    1

  • Pages from-to

    3653-3852

  • UT code for WoS article

  • EID of the result in the Scopus database